A221208
|
Alliance
|
Randomized Phase II Study: Corticosteroids and Bevacizumab vs. Corticosteroids and Placebo (BeSt) for Radionecrosis after Radiosurgery for Brain Metastases
|
Cancer Prevention and Control CIRB
|
A221405
|
Alliance
|
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women with Endocrine Responsive Breast Cancer who Desire Pregnancy
|
Cancer Prevention and Control CIRB
|
A221504
|
Alliance
|
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
|
Cancer Prevention and Control CIRB
|
A221505
|
Alliance
|
RT Charm: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation with Breast Reconstruction
|
Cancer Prevention and Control CIRB
|
A221602
|
Alliance
|
Olanzapine with or without fosaprepitant for the prevention of chemotherapy induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
|
Cancer Prevention and Control CIRB
|
A221701
|
Alliance
|
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
|
Cancer Prevention and Control CIRB
|
A221702
|
Alliance
|
ARM: Axillary Reverse Mapping – A Prospective Trial To Study Rates Of Lymphedema And Regional Reccurence After Sentinel Lymph Node Biopsy And Sentinel Lymph Node Biopsy Followed By Axillary Lymph Node Dissection With And Without Axillary Reverse Mapping
|
Cancer Prevention and Control CIRB
|
A221801
|
Alliance
|
The Revitalize Trial: Reducing Vaginal Atrophy with Fractional CO2 Laser for Breast Cancer Survivors
|
Cancer Prevention and Control CIRB
|
A221803
|
Alliance
|
Mepitel Film for the Reduction of Radiation Dermatitis in Breast Cancer Patients Undergoing Post-Mastectomy Radiation Therapy: A Randomized Phase III Clinical Trial
|
Cancer Prevention and Control CIRB
|
A221805
|
Alliance
|
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
|
Cancer Prevention and Control CIRB
|